Jason Moffat
Fondatore presso Empirica Therapeutics, Inc.
Provenienza dei contatti di primo grado di Jason Moffat
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Empirica Therapeutics, Inc.
 Empirica Therapeutics, Inc. BiotechnologyHealth Technology Empirica Therapeutics, Inc. develops novel allogeneic living drugs. The company was founded by Sheila Singh and Jason Moffat in July, 2018 and is headquartered in Hamilton, Canada.
1
| Subsidiary | Biotechnology | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Jason Moffat tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
Centre For Probe Development & Commercialization
 Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin. | Pharmaceuticals: Major | Director/Board Member |
Statistiche
Distribuzione geografica
| Canada | 2 |
Settori
| Health Technology | 2 |
Posizioni
| Chief Executive Officer | 1 |
| Founder | 1 |
| Director/Board Member | 1 |
| Independent Dir/Board Member | 1 |
Contatti più connessi
| Insiders | |
|---|---|
| Sheila Singh | 2 |
- Borsa valori
- Insiders
- Jason Moffat
- Connessioni Società
